BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32619494)

  • 1. Induced Fetal Human Muscle Stem Cells with High Therapeutic Potential in a Mouse Muscular Dystrophy Model.
    Zhao M; Tazumi A; Takayama S; Takenaka-Ninagawa N; Nalbandian M; Nagai M; Nakamura Y; Nakasa M; Watanabe A; Ikeya M; Hotta A; Ito Y; Sato T; Sakurai H
    Stem Cell Reports; 2020 Jul; 15(1):80-94. PubMed ID: 32619494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. iMyoblasts for ex vivo and in vivo investigations of human myogenesis and disease modeling.
    Guo D; Daman K; Chen JJ; Shi MJ; Yan J; Matijasevic Z; Rickard AM; Bennett MH; Kiselyov A; Zhou H; Bang AG; Wagner KR; Maehr R; King OD; Hayward LJ; Emerson CP
    Elife; 2022 Jan; 11():. PubMed ID: 35076017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core Transcription Factors Promote Induction of PAX3-Positive Skeletal Muscle Stem Cells.
    Sato T; Higashioka K; Sakurai H; Yamamoto T; Goshima N; Ueno M; Sotozono C
    Stem Cell Reports; 2019 Aug; 13(2):352-365. PubMed ID: 31353225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
    He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
    Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
    Lala-Tabbert N; Fu D; Wiper-Bergeron N
    Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 editing of directly reprogrammed myogenic progenitors restores dystrophin expression in a mouse model of muscular dystrophy.
    Domenig SA; Bundschuh N; Lenardič A; Ghosh A; Kim I; Qabrati X; D'Hulst G; Bar-Nur O
    Stem Cell Reports; 2022 Feb; 17(2):321-336. PubMed ID: 34995499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.
    Lin B; Li Y; Han L; Kaplan AD; Ao Y; Kalra S; Bett GC; Rasmusson RL; Denning C; Yang L
    Dis Model Mech; 2015 May; 8(5):457-66. PubMed ID: 25791035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice.
    Nance ME; Shi R; Hakim CH; Wasala NB; Yue Y; Pan X; Zhang T; Robinson CA; Duan SX; Yao G; Yang NN; Chen SJ; Wagner KR; Gersbach CA; Duan D
    Mol Ther; 2019 Sep; 27(9):1568-1585. PubMed ID: 31327755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PITX2 Enhances the Regenerative Potential of Dystrophic Skeletal Muscle Stem Cells.
    Vallejo D; Hernández-Torres F; Lozano-Velasco E; Rodriguez-Outeiriño L; Carvajal A; Creus C; Franco D; Aránega AE
    Stem Cell Reports; 2018 Apr; 10(4):1398-1411. PubMed ID: 29641992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
    Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
    Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy.
    Siemionow M; Cwykiel J; Heydemann A; Garcia J; Marchese E; Siemionow K; Szilagyi E
    Stem Cell Rev Rep; 2018 Jun; 14(3):370-384. PubMed ID: 29546607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell-based therapies for Duchenne muscular dystrophy.
    Sun C; Serra C; Lee G; Wagner KR
    Exp Neurol; 2020 Jan; 323():113086. PubMed ID: 31639376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro.
    Vieira NM; Brandalise V; Zucconi E; Jazedje T; Secco M; Nunes VA; Strauss BE; Vainzof M; Zatz M
    Biol Cell; 2008 Apr; 100(4):231-41. PubMed ID: 17997718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures.
    Haynes P; Kernan K; Zhou SL; Miller DG
    Skelet Muscle; 2017 Jun; 7(1):13. PubMed ID: 28637492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of hiPSC-Derived Muscle Progenitors Reveals Distinctive Markers for Myogenic Cell Purification Toward Cell Therapy.
    Nalbandian M; Zhao M; Sasaki-Honda M; Jonouchi T; Lucena-Cacace A; Mizusawa T; Yasuda M; Yoshida Y; Hotta A; Sakurai H
    Stem Cell Reports; 2021 Apr; 16(4):883-898. PubMed ID: 33798449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion.
    Gonçalves MA; de Vries AA; Holkers M; van de Watering MJ; van der Velde I; van Nierop GP; Valerio D; Knaän-Shanzer S
    Hum Mol Genet; 2006 Jan; 15(2):213-21. PubMed ID: 16321987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednisolone rescues Duchenne muscular dystrophy phenotypes in human pluripotent stem cell-derived skeletal muscle in vitro.
    Al Tanoury Z; Zimmerman JF; Rao J; Sieiro D; McNamara HM; Cherrier T; Rodríguez-delaRosa A; Hick-Colin A; Bousson F; Fugier-Schmucker C; Marchiano F; Habermann B; Chal J; Nesmith AP; Gapon S; Wagner E; Gupta VA; Bassel-Duby R; Olson EN; Cohen AE; Parker KK; Pourquié O
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34260377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs.
    Hicks MR; Hiserodt J; Paras K; Fujiwara W; Eskin A; Jan M; Xi H; Young CS; Evseenko D; Nelson SF; Spencer MJ; Handel BV; Pyle AD
    Nat Cell Biol; 2018 Jan; 20(1):46-57. PubMed ID: 29255171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR).
    Elhussieny A; Nogami K; Sakai-Takemura F; Maruyama Y; Takemura N; Soliman WT; Takeda S; Miyagoe-Suzuki Y
    Stem Cell Res Ther; 2021 Oct; 12(1):532. PubMed ID: 34627382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients.
    Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Shemer Y; Baskin P; Reiter I; Willi L; Freimark D; Gherghiceanu M; Monserrat L; Scherr M; Hilfiker-Kleiner D; Arad M; Michele DE; Binah O
    J Cell Mol Med; 2019 Mar; 23(3):2125-2135. PubMed ID: 30618214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.